~~<i id='4E5C4E381E'><strike id='4E5C4E381E'><tt id='4E5C4E381E'><pre id='4E5C4E381E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：fashion 2025-09-27 06:03:21 - browse：8784

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Changes to biosimilar regulatory framework must prioritize patients

knowledge

focus

explore

hotspot

OLIVIERDOULIERY/AFPviaGettyImagesMedicalstudentsexperiencesignificantmentaldistress,includinghighrat

WSS

The Pandemic Treaty must support building strong health systems

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Ionis drug prevents swelling attacks due to hereditary angioedema

Let's speed up science by embracing open access publishing

It's been 20 years since Dolly the sheep. Where's my clone?

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

hotspot

hotspot

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Emergency workers more likely to restrain Black patients: study

Medicare details structure of new drug price negotiation program

With trial win, GSK could get blood cancer drug back on market

Bright Health sells Medicare Advantage business to Molina

STAT Virtual Event: Putting AI to the Test

Duchenne breakthrough therapy leaves behind pioneering families

Ultragenyx gene therapy for rare liver ailment succeeds in late

Supreme Court strikes down use of affirmative action

Let's speed up science by embracing open access publishing

focus

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Senators: Long

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Lasker Awards 2023: Winners in biomedical research

Intarcia’s device

focus

focus

explore

hotspot